Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MARSHALL UNIVERSITY

Home Clinical Trial Sponsors and OrganizationsMARSHALL UNIVERSITY

MARSHALL UNIVERSITY

43 43, Race Cource Road, Race Course Road, Bengaluru, Karnataka, Indiawww.marshall.edu1,963 employeesEstablished: 1837-01-01

Also known as:

marshall university graduate college

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

20

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1837

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

11

55.0%

Phase 2

2

10.0%

Phase 3

2

10.0%

Trial Status Distribution

Active, not recruiting

1

5.0%

Completed

6

30.0%

Enrolling By Invitation

1

5.0%

Recruiting

4

20.0%

Terminated

2

10.0%

Unknown

5

25.0%

Withdrawn

1

5.0%

Clinical Trials

Trials sponsored by this organization (20)

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Feb 2024450 participants

Biofeedback Training Targeting at Knee Proprioception

Jan 202414 participants

Enchasing Polyp Detection: The Effect of Adding Polyp Detection Attachment Device to Computer Aid Detection System.

Enrolling By Invitation

Oct 20231,766 participants

Treatment of Elevated Blood Pressures in Early Pregnancy

Jul 20232 participants

Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy

Dec 2022100 participants

The Effect of Blood on the PC Ratio During Pregnancy

Jun 202220 participants

Implementation of GLA:D Program in West Virginians With Osteoarthritis of the Knee

Aug 202124 participants

Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay

Aug 2021159 participants

Page 1 of 3

Approvals

No approval data available

News

Lofexidine Trial Launched for Neonatal Opioid Withdrawal Syndrome

- Marshall University is conducting a clinical trial to assess oral lofexidine, a non-opioid medication, for treating Neonatal Opioid Withdrawal Syndrome (NOWS). - The Phase 2 trial aims to evaluate the safety and pharmacokinetics of lofexidine in newborns exposed to opioids prenatally. - Unlike opioid-based treatments, lofexidine does not produce euphoria or addiction potential, offering a potentially safer alternative. - The study will monitor NOWS symptoms using the Modified Finnegan Neonatal Abstinence Scoring Tool (mFNAST) and assess treatment duration.

On this page

Overview
Clinical Trials20
Approvals
News1

Back to Organizations